IBD management often requires long-term treatment based on a combination of drugs to
control the disease. Clinicians should be aware of possible drug interactions and side …

Inflammatory bowel disease therapy can be considered in several subcategories, and this
review is designed to provide selective updates for some of the most important therapeutic …

Inflammatory bowel disease (IBD) is a general term for chronic or remitting/relapsing
inflammatory diseases of the intestinal tract and generally refers to ulcerative colitis (UC) …

BACKGROUND Despite the advent of biological drugs, conventional therapy continues to
be used in moderate to severe inflammatory bowel disease (MS-IBD). This study …

Most patients with inflammatory bowel diseases (IBD) are offered conventional medical
therapy, because emerging therapies for IBD are regulated by health-care jurisdiction and …

S3 Evidence-Based Systematic Review on Medical Therapies for IBD also has a high
incidence in New Zealand, suggesting that the disease may get more common the further …

Inflammatory bowel disease (IBD) is a chronic heterogeneous group of diseases that has
undergone major advances in the understanding of its etiology and pathogenesis in recent …

New targets in inflammatory bowel disease therapy: 2021 : Current Opinion in
Gastroenterology New targets in inflammatory bowel disease therapy: 2021 : Current …

Short-and long-term treatment targets in inflammatory bowel diseases (IBDs) evolved during
the last decade, shifting from symptom control to endoscopic healing and patient-centered …

Inflammatory bowel disease (IBD) represents a group of idiopathic, chronic, inflammatory
intestinal conditions. Its two main disease categories are: Crohn's disease (CD) and …